| Time | Session |
|---|---|
| 08:30 | Welcome Coffee |
| 09:15 | Opening Remarks |
| 09:20 | Welcome Address: Christian Leumann – Rector of the University of Bern |
| 09:30 | Keynote I: Mustafa Diken – Vice President of Vaccines & Immunology, BioNTech – “mRNA based vaccines and beyond” (Chair: Jonathan Hall) |
| 10:10 | Company Presentations I: Mario Jauker – Bachem Torsten Schmidt – Lonza Soham Mandal – Axolabs Nicolas Chornet – Moderna |
| 11:10 | Coffee Break Sponsored by:  |
| 11:40 | Panel I – RNA Therapeutics in Switzerland: How to Join Forces: Mustafa Diken – BioNTech Oliver Mühlemann – University of Bern & Director NCCR RNA & Disease Nicole Schaad – State Secretariat for Education, Research and Innovation Volker Thiel – EDI & University of Bern, Swiss National COVID-19 Science Task Force Moderated by Dominik Theler |
| 12:25 | Company Talent Presentations: Daniel Wanner – Bachem Cédric Vonarburg – CSL Behring Dmitry Kopelyanskiy – Haya Theo Rowley – Moderna Erich Koller – Roche Stefan Reber – Skyhawk Versameb – Klaas Zuideveld |
| 13:00 | Lunch & Meet the Talent Session Lunch sponsored by:  |
| 14:15 | Keynote II: Shalini Andersson – Vice President Oligonucleotide Discovery, AstraZeneca – “Developing Next Generation Oligonucleotide therapeutics” (Chair: Jonathan Hall) |
| 14:55 | Panel II: Investors Bettina Ernst – Bernina BioInvest Gabriela Ecco – +ND Capital Klaas Zuideveld – Versameb Moderated by Carsten Laue |
| 15:30 | Coffee Break Sponsored by:  |
| 16:00 | Company Presentations II: Tom Edwardson – Procavea Riccardo Dainese – Alithea Genomics Stefanie Urlinger – Cimeio Daniel Blessing – Haya Friedrich Metzger – Versameb |
| 16:50 | Swiss Regulatory Aspects – Julia Djonova – Swissmedic |
| 17:05 | Panel III – Technological Trends & Needs Shalini Andersson – VP Oligonucleotide Discovery, AstraZeneca Julia Djonova – Swissmedic Lukas Jeker – University of Basel & co-founder Cimeio Markus Stoffel – ETH Zurich & SAB Alnylam Moderated by Jonathan Hall |
| 17:50 | Concluding Remarks |
| 18:00 | Apéro sponsored by the Bern Economic Development Agency  |
| | |